Ph1a/b LOXO-435 in Solids with FGFR3 Alterations

Phase I Clinical Trial

AN OPEN-LABEL MULTICENTER STUDY OF LOXO-435 (LY3866288) IN ADVANCED SOLID TUMOR MALIGNANCIES WITH FGFR3 ALTERATIONS (LOXO-FG3-22001)

Indication: Urothelial Cancer, Urothelial Cancer
Trial Number: 05614739
Trial Status: OPEN

Learn more about this clinical trial.

Participating Locations